跳至主要内容
临床试验/JPRN-jRCTs041180075
JPRN-jRCTs041180075进行中(未招募)2 期

Effect of lipid metabolism related genotypes on the treatment response by PUFA add-on therapy for bipolar disorder - omega3 PUFA add-on therapy for bipolar disorder: genotype stratified analysis

Iwata Nakao0 个研究点目标入组 60 人开始时间: 2019年3月11日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 64age old(—)
性别
All

入选标准

  • Bipolar Disorder (I and II) diagnosed by DSM-V

排除标准

  • Bipolar disorder (rapid cycling) diagnosed by DSM-V
  • patients who are taking EPA/DHA
  • Allergy for EPA DHA
  • metabolic syndrome at the enrollment
  • side effect by EPA DHA
  • high risk of hemorrhage
  • patients who received more than 3 types of antipsychotics
  • patients who received more than 3 types of antidepressants (exclude antidepressants which use only as hypnotics)

研究者

发起方
Iwata Nakao

相似试验

omega3 PUFA add-on therapy for bipolar disorder:... | 临床试验